DD123466A1 - - Google Patents
Info
- Publication number
- DD123466A1 DD123466A1 DD18977575A DD18977575A DD123466A1 DD 123466 A1 DD123466 A1 DD 123466A1 DD 18977575 A DD18977575 A DD 18977575A DD 18977575 A DD18977575 A DD 18977575A DD 123466 A1 DD123466 A1 DD 123466A1
- Authority
- DD
- German Democratic Republic
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DD18977575A DD123466A1 (enrdf_load_stackoverflow) | 1975-12-01 | 1975-12-01 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DD18977575A DD123466A1 (enrdf_load_stackoverflow) | 1975-12-01 | 1975-12-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
DD123466A1 true DD123466A1 (enrdf_load_stackoverflow) | 1976-12-20 |
Family
ID=5502579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD18977575A DD123466A1 (enrdf_load_stackoverflow) | 1975-12-01 | 1975-12-01 |
Country Status (1)
Country | Link |
---|---|
DD (1) | DD123466A1 (enrdf_load_stackoverflow) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0021000A3 (en) * | 1979-05-23 | 1981-12-02 | F. Hoffmann-La Roche & Co. Aktiengesellschaft | Substituted acetophenones, their preparation, their application and pharmaceutical compositions containing them |
EP0540143A3 (enrdf_load_stackoverflow) * | 1991-08-02 | 1995-01-04 | Medivir Ab | |
US5593993A (en) * | 1991-08-02 | 1997-01-14 | Medivir Ab | Method for inhibition of HIV related viruses |
WO2007017764A3 (en) * | 2005-05-18 | 2007-07-05 | Neuraxon Inc | Substituted benzimidazole compounds with dual nos inhibitory activity and muopioid agonist activity |
WO2007106525A1 (en) * | 2006-03-13 | 2007-09-20 | The Regents Of The University Of California | Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
US8455652B2 (en) | 2003-04-03 | 2013-06-04 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Inhibitors for the soluble epoxide hydrolase |
US8476043B2 (en) | 2004-10-20 | 2013-07-02 | The Regents Of The University Of California | Inhibitors for the soluble epoxide hydrolase |
US9296693B2 (en) | 2010-01-29 | 2016-03-29 | The Regents Of The University Of California | Acyl piperidine inhibitors of soluble epoxide hydrolase |
-
1975
- 1975-12-01 DD DD18977575A patent/DD123466A1/xx unknown
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4327088A (en) | 1979-05-23 | 1982-04-27 | Hoffmann-La Roche Inc. | Phosphonooxy- or glycosyloxy-substituted acrylophenones, compositions and uses thereof |
EP0021000A3 (en) * | 1979-05-23 | 1981-12-02 | F. Hoffmann-La Roche & Co. Aktiengesellschaft | Substituted acetophenones, their preparation, their application and pharmaceutical compositions containing them |
EP0540143A3 (enrdf_load_stackoverflow) * | 1991-08-02 | 1995-01-04 | Medivir Ab | |
US5593993A (en) * | 1991-08-02 | 1997-01-14 | Medivir Ab | Method for inhibition of HIV related viruses |
US5658907A (en) * | 1991-08-02 | 1997-08-19 | Medivir A/B | Compounds and methods for inhibition of HIV and related viruses |
US5714503A (en) * | 1991-08-02 | 1998-02-03 | Medivir Ab | Compounds and methods for inhibition of HIV and related viruses |
US8455652B2 (en) | 2003-04-03 | 2013-06-04 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Inhibitors for the soluble epoxide hydrolase |
US8476043B2 (en) | 2004-10-20 | 2013-07-02 | The Regents Of The University Of California | Inhibitors for the soluble epoxide hydrolase |
US7919510B2 (en) | 2005-05-18 | 2011-04-05 | Neuraxon, Inc | Substituted benzimidazole compounds with dual NOS inhibitory activity and mu opioid agonist activity |
WO2007017764A3 (en) * | 2005-05-18 | 2007-07-05 | Neuraxon Inc | Substituted benzimidazole compounds with dual nos inhibitory activity and muopioid agonist activity |
US8188289B2 (en) | 2006-03-13 | 2012-05-29 | The Regents Of The University Of California | Conformationally restricted urea inhibitors of soluble epoxide hydrolase |
AU2007225170B2 (en) * | 2006-03-13 | 2012-11-01 | The Regents Of The University Of California | Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
WO2007106525A1 (en) * | 2006-03-13 | 2007-09-20 | The Regents Of The University Of California | Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
US8501783B2 (en) | 2006-03-13 | 2013-08-06 | The Regents Of The University Of California | Conformationally restricted urea inhibitors of soluble epoxide hydrolase |
US9029550B2 (en) | 2006-03-13 | 2015-05-12 | The Regents Of The University Of California | Conformationally restricted urea inhibitors of soluble epoxide hydrolase |
US9296693B2 (en) | 2010-01-29 | 2016-03-29 | The Regents Of The University Of California | Acyl piperidine inhibitors of soluble epoxide hydrolase |